(Q80163050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930652%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

5,8-Epidioxysterols and related derivatives from a Chinese soft coral Sinularia flexibilis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930652%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1 reference

(1S,3R,8S,9S,10R,11R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-1,3,11-triol

1 reference

5a,8a-Epidioxyergosta-6,9(11),22-trien-3

1 reference

(22R,23E)-22,28-Epidioxyergosta-5,23-diene-3beta-ol

1 reference

[(1S,3R,8S,9S,10R,11R,13S,14S,17R)-1,3,11-trihydroxy-10-methyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-13-yl]methyl acetate

1 reference

(1S,3R,8S,9S,10R,11R,13S,14S,17R)-1,3,11-trihydroxy-10-methyl-17-[(1R)-1-[(1S,2R)-2-methyl-2-[(2R)-3-methylbutan-2-yl]cyclopropyl]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-13-carbaldehyde

1 reference

(1S,2R,5R,6R,9R,10R,13S,15S)-6,10-dimethyl-5-[(1R)-1-[(1S,2R)-2-[(2R)-3-methylbutan-2-yl]cyclopropyl]ethyl]-16,17-dioxapentacyclo[13.2.2.01,9.02,6.010,15]nonadec-18-en-13-ol

1 reference

5alpha,8alpha-Epidioxyergost-6-en-3beta-ol

1 reference

Ergosta-5,24(28)-diene-3beta,7alpha-diol

1 reference

(22S,23E)-22,28-Epidioxyergosta-5,23-diene-3beta-ol

1 reference

(1S,3R,8S,9S,10R,11R,13S,14S,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-1,3,11-trihydroxy-10-methyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-13-carboxylic acid

1 reference

(1S,3R,8S,9S,10R,11R,13S,14S,17R)-3-acetyloxy-1,11-dihydroxy-10-methyl-17-[(1R)-1-[(1S,2R)-2-methyl-2-[(2R)-3-methylbutan-2-yl]cyclopropyl]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-13-carboxylic acid

1 reference

24-Methylenecholesta-5-ene-1alpha,3beta,11alpha,18-tetraol

1 reference

(1S,3R,8S,9S,10R,11R,13S,14S,17R)-1,3,11-trihydroxy-10-methyl-17-[(1R)-1-[(1S,2R)-2-methyl-2-[(2R)-3-methylbutan-2-yl]cyclopropyl]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-13-carboxylic acid

1 reference

(22E)-5alpha,8alpha-Epidioxy-23-methylergosta-6,22-dien-3beta-ol

1 reference

5alpha,8alpha-Epidioxygorgosta-6-ene-3beta-ol

1 reference

5alpha,8alpha-Epidioxyergosta-6,9(11),24(28)-triene-3beta-ol

1 reference

(24S)-Ergosta-5-ene-1alpha,3beta,11alpha,18-tetraol

1 reference

5alpha,8alpha-Epidioxyergosta-6,24(28)-diene-3beta-ol

1 reference

5alpha,8alpha-Epidioxygorgosta-6,9(11)-diene-3beta-ol

1 reference

[(1S,3R,8S,9S,10R,11R,13S,14S,17R)-1,3,11-triacetyloxy-10-methyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-13-yl]methyl acetate

1 reference

ergosterol endoperoxide

1 reference

(1S,3R,8S,9S,10R,11R,13S,14S,17R)-1,3,11-trihydroxy-10-methyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-13-carboxylic acid

1 reference

(1S,3R,8S,9S,10R,11R,13S,14S,17R)-13-(hydroxymethyl)-10-methyl-17-[(1R)-1-[(1S,2R)-2-methyl-2-[(2R)-3-methylbutan-2-yl]cyclopropyl]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-1,3,11-triol

1 reference

(24S)-3beta-Acetoxy-1alpha,11alpha-dihydroxyergosta-5-ene-18-oic acid

1 reference

24-methylenecholesterol

1 reference

[(1S,3R,8S,9S,10R,11R,13S,14S,17R)-1,3,11-trihydroxy-10-methyl-17-[(1R)-1-[(1S,2R)-2-methyl-2-[(2R)-3-methylbutan-2-yl]cyclopropyl]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-13-yl]methyl acetate

1 reference

4

Peter Proksch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930652%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Shanjiang Yu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930652%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Zhiwei Deng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930652%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Leen van Ofwegen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930652%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Wenhan Lin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930652%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

November 2006

1 reference

16 September 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930652%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930652%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

955-959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930652%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

11-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930652%20AND%20SRC:MED&resulttype=core&format=json

10.1016/J.STEROIDS.2006.07.002

29 December 2019

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930652%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference